Posted by BRENDA POLLOCK on Aug 15, 2018
 
 
GUEST SPEAKER
Our very own Brian Dallaire.
 
 
 
 
Brian graduated from Thornton Academy. He lost a family member to cancer at a young age, so Brian decided then to do study and have a career in cancer research.   He attended Pharmacy school at the University of Rhode Island and obtain his doctorate’s degree(Pharm.D.) at University of Cincinnati.
 
Brian began his career in cancer research  Park Davis then on to DuPont then to IDEC in San Diego.
 
Winner of a Nobel Prize in 1908, Paul Ehrlich completed successful research in the area of Chemotherapy. He proposed the first antibodies that were approved in 1986. 
In 1993 Brian was lead a small team their first successful human trail and carried on to complete all the trials that resulted to it's approval.
In 1997, they submitted their research to the FDA and received approval later that year.
RITUXAN is a $9 billion-dollar drug used around the world, number one for fighting cancer and number two for all drugs used worldwide. Combined with CHOP (classic Chemo medication) RITUXAN has cured more than fifty-thousand people per year with Non-Hodgkin's Lymphoma.
 
President Joe presented our speaker with an official Biddeford Saco ROTARY coffee mug for his presentation.  Thank you, Brian, for your informative presentation and your dedication to a career in cancer research.
 
Sponsors